Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBSHealth CareMedical/Dental InstrumentsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
INBS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.21M
- Forward P/E
- 4.49
- EPS (TTM)
- -$8.44
- Dividend yield
- None
- 52-week range
- 1.52 – 24.90
- Day range
- 1.55 – 1.64
- Volume / Avg
- 17.45K / 160.86K
- Beta
- —
- Shares outstanding
- 3.32M
52-week range
INBS stock today
On Oct 8, INBS ended the session at $1.57, shedding $0.02 (1.26%), versus the S&P 500's 0.47% decline. Trading was light, with 17.45K shares changing hands, about 11% of the average daily volume. At this level, INBS sits near the bottom of its 52-week range of $1.52 to $24.90: 93.7% below the high and 3.3% above the low.
Intelligent Bio Solutions has posted a net loss over the last twelve months (EPS of -$8.44), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Intelligent Bio Solutions
Company profileIntelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Harry Simeonidis
- Headquarters
- New York, NY
- Employees
- 59
- IPO year
- 2020
- Website
- ibs.inc
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$12.00+664.33%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Intelligent Bio Solutions peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ICCMIceCure Medical Ltd. | 1.13 | -1.74% | $5.24M | vs INBS |
| VVOSVivos Therapeutics Inc. | 0.1495 | -0.99% | $5.02M | vs INBS |
| SNOASonoma Pharmaceuticals Inc. | 1.16 | -4.92% | $5.55M | vs INBS |
| NVNOenVVeno Medical Corporation | 8.18 | -2.68% | $5.68M | vs INBS |
| AMIXAutonomix Medical Inc. | 3.13 | -8.21% | $6.13M | vs INBS |
| WOKWORK Medical Technology Group LTD Class A | 1.52 | -1.94% | $6.79M | vs INBS |
| BJDXBluejay Diagnostics Inc. | 0.8156 | +0.68% | $3.64M | vs INBS |
| ADGMAdagio Medical Holdings Inc | 0.13 | -2.84% | $3.53M | vs INBS |
Indexes, lists and sector
Intelligent Bio Solutions stock FAQ
What is Intelligent Bio Solutions's stock price today?
INBS last traded at $1.57 as of Oct 8, 4:00 PM EDT, down 1.26% on the day. Prices are delayed at least 15 minutes.
Who is Intelligent Bio Solutions's CEO?
Mr. Harry Simeonidis is the chief executive officer of Intelligent Bio Solutions Inc., which has about 59 employees.
What is the INBS 52-week high?
The 52-week high for INBS is $24.90 and the 52-week low is $1.52. The stock is currently 93.7% below its high.